Quad elvitegravir/cobicistat/emtricitabine/tenofovir: Phase III started

Gilead began the double-blind, U.S. and Puerto Rican Phase III Study 102 trial to compare Quad to Atripla efavirenz/emtricitabine/tenofovir disoproxil fumarate for 96 weeks in about 700 HIV patients....